Insmed Incorporated (IM8N)
FSX
Real-time Data
06:00 AM
Day's Range
90.6052 wk Range
78.77Overview - IM8N - Insmed Incorporated
Key Statistics
Valuation
Enterprise Value
19.32B
P/E (Trailing)
‪-16.00‬
P/E (Forward)
‪-31.91‬
PEG Ratio
‪0.16‬
Price / Sales (TTM)
‪19.72‬
Price / Book
‪33.95‬
EV / EBITDA
‪-27.70‬
Profitability
Gross Margin
‪84.20%‬
Profit Margin
‪-76.94%‬
Operating Margin
‪-23.80%‬
Return on Assets
‪-22.16%‬
Return on Equity
‪-87.21%‬
Ownership
Shares Outstanding
218.28M
Float
216.93M
Held by Insiders
‪0.50%‬
Held by Institutions
‪105.00%‬
Price stats
Beta
‪0.81‬
50-Day Avg
‪103.19‬
200-Day Avg
‪114.13‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - IM8N - Insmed Incorporated
Peers - IM8N - Insmed Incorporated
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- IM8NFSXInsmed Incorporated22.44BMarket Cap-13.84%52-week change-16.01P/E (Trailing)‪-76.94%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- 0QFFSXModerna Inc.69.12BMarket Cap+87.76%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.53.43BMarket Cap+42.53%52-week change179.66P/E (Trailing)‪30.74%‬Profit Margin
- 1AEFSXargenx SE52.63BMarket Cap+28.29%52-week change36.62P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt50.36BMarket Cap+25.47%52-week change34.88P/E (Trailing)‪32.26%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.58BMarket Cap+78.78%52-week change-29.47P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - IM8N - Insmed Incorporated
About
Insmed Incorporated is a global biopharmaceutical company that develops and commercializes therapies for patients with serious and rare diseases. Its current portfolio includes an approved treatment for Mycobacterium avium complex lung disease, along with clinical-stage programs focused on pulmonary and inflammatory…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
